Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression

[1] Lyon AR(2022)2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Eur Heart J 43 4229-4361

[2] López-Fernández T(2019)Abatacept for severe immune checkpoint inhibitor-associated myocarditis N Engl J Med 380 2377-2379

[3] Couch LS(2012)Myocarditis Lancet 379 738-747

[4] Asteggiano R(2009)Myocarditis N Engl J Med 360 1526-1538

[5] Salem JE(2016)Fulminant Myocarditis with Combination Immune Checkpoint Blockade N Engl J Med 375 1749-1755

[6] Allenbach Y(2021)Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance Annu Rev Pathol 16 223-249

[7] Vozy A(2001)Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice Science 291 319-322

[8] Brechot N(2020)Immune Checkpoint Inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment J Am Heart Assoc 9 e013757-1764

[9] Johnson DB(2018)Myocarditis in patients treated with immune checkpoint Inhibitors J Am Coll Cardiol 71 1755-121

[10] Moslehi JJ(2019)Diagnosis of immune checkpoint inhibitor-associated myocarditis: a systematic review Int J Cardiol 296 113-957

[1] Lyon AR(2022)2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Eur Heart J 43 4229-4361

[2] López-Fernández T(2019)Abatacept for severe immune checkpoint inhibitor-associated myocarditis N Engl J Med 380 2377-2379

[3] Couch LS(2012)Myocarditis Lancet 379 738-747

[4] Asteggiano R(2009)Myocarditis N Engl J Med 360 1526-1538

[5] Salem JE(2016)Fulminant Myocarditis with Combination Immune Checkpoint Blockade N Engl J Med 375 1749-1755

[6] Allenbach Y(2021)Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance Annu Rev Pathol 16 223-249

[7] Vozy A(2001)Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice Science 291 319-322

[8] Brechot N(2020)Immune Checkpoint Inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment J Am Heart Assoc 9 e013757-1764

[9] Johnson DB(2018)Myocarditis in patients treated with immune checkpoint Inhibitors J Am Coll Cardiol 71 1755-121

[10] Moslehi JJ(2019)Diagnosis of immune checkpoint inhibitor-associated myocarditis: a systematic review Int J Cardiol 296 113-957